In Vitro Release Testing (IVRT)
In vitro release testing (IVRT) is an essential FDA-mandated assessment that supports post-approval manufacturing changes in compliance with SUPAC-SS requirements. At BioLink, we specialize in IVRT studies, providing comprehensive services to the pharmaceutical industry. Here’s what sets us apart:
Our experienced team designs and executes discriminatory IVRT methods. These protocols allow us to compare generic drug formulations with brand products accurately. By profiling the performance characteristics of various prototype formulations, we help clients make informed decisions during topical drug product development.